Header Logo

Connection

KATHRYN SHELTON to Emtricitabine

Back to Details
This is a "connection" page, showing publications KATHRYN SHELTON has written about Emtricitabine.
KATHRYN SHELTON
Connection Strength
0.160
Emtricitabine
  1. Transcutaneously refillable nanofluidic implant achieves sustained level of tenofovir diphosphate for HIV pre-exposure prophylaxis. J Control Release. 2018 09 28; 286:315-325.
    View in: PubMed
    Score: 0.160
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.